Cardinal Health, Inc. $CAH Shares Purchased by Czech National Bank

Key Points

• Czech National Bank increased its investment in Cardinal Health by 5.1% in the second quarter, acquiring an additional 2,857 shares to hold a total of 58,341 shares valued at approximately $9.8 million.
• Despite some insider selling, including significant transactions by CEO Stephen M. Mason and insider Jessica L. Mayer, institutional investors continue to dominate ownership at 87.17% of the company's stock.
• Analysts have varying ratings for Cardinal Health, with an average consensus of "Moderate Buy" and a current target price of $165.93, reflecting positive sentiment from eleven analysts.

Czech National Bank grew its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 5.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 58,341 shares of the company's stock after purchasing an additional 2,857 shares during the quarter. Czech National Bank's holdings in Cardinal Health were worth $9,801,000 at the end of the most recent reporting period.

Other institutional investors also recently added to or reduced their stakes in the company. Greykasell Wealth Strategies Inc. purchased a new position in Cardinal Health in the first quarter worth approximately $26,000. Tompkins Financial Corp grew its position in shares of Cardinal Health by 106.7% during the first quarter. Tompkins Financial Corp now owns 248 shares of the company's stock worth $34,000 after acquiring an additional 128 shares during the last quarter. GW&K Investment Management LLC grew its position in shares of Cardinal Health by 113.4% during the first quarter. GW&K Investment Management LLC now owns 271 shares of the company's stock worth $37,000 after acquiring an additional 144 shares during the last quarter. NBC Securities Inc. purchased a new position in shares of Cardinal Health during the first quarter worth approximately $48,000. Finally, Zions Bancorporation National Association UT purchased a new position in shares of Cardinal Health during the first quarter worth approximately $52,000. Hedge funds and other institutional investors own 87.17% of the company's stock.

Insider Buying and Selling at Cardinal Health

In related news, insider Ola M. Snow sold 28,151 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the sale, the insider directly owned 15,431 shares of the company's stock, valued at approximately $2,298,293.14. This represents a 64.59% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Michelle D. Greene sold 13,500 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $2,009,070.00. Following the sale, the insider directly owned 14,976 shares in the company, valued at approximately $2,228,728.32. This represents a 47.41% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 271,676 shares of company stock worth $40,489,525. 0.09% of the stock is owned by insiders.

Cardinal Health Price Performance

NYSE CAH traded down $0.48 on Friday, reaching $149.56. The company had a trading volume of 3,661,933 shares, compared to its average volume of 2,393,175. The firm has a market capitalization of $35.53 billion, a PE ratio of 23.19, a P/E/G ratio of 1.26 and a beta of 0.73. Cardinal Health, Inc. has a 1 year low of $106.54 and a 1 year high of $168.44. The firm has a 50-day moving average of $153.29 and a 200-day moving average of $148.23.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping analysts' consensus estimates of $2.03 by $0.05. The firm had revenue of $60.16 billion during the quarter, compared to analysts' expectations of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.Cardinal Health's quarterly revenue was up .5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, sell-side analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be paid a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a dividend yield of 1.4%. The ex-dividend date is Wednesday, October 1st. Cardinal Health's dividend payout ratio is 31.63%.

Wall Street Analyst Weigh In

CAH has been the topic of a number of analyst reports. Citigroup reiterated a "neutral" rating and issued a $170.00 price objective (up from $157.00) on shares of Cardinal Health in a research report on Friday, June 13th. Robert W. Baird lifted their price target on Cardinal Health from $197.00 to $203.00 and gave the stock an "outperform" rating in a research note on Wednesday, August 13th. UBS Group reaffirmed a "buy" rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Jefferies Financial Group set a $150.00 target price on shares of Cardinal Health in a research note on Tuesday, August 12th. Finally, Argus set a $189.00 target price on shares of Cardinal Health in a research note on Friday, August 22nd. Eleven research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $165.93.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.